Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Whether you inject in your abdomen, thigh, or upper arm, the medication reaches the same blood levels and activates the same receptors throughout your body
Unleash the power of peptides Ready to do more than just lose a few pounds
In the Phase 2 clinical trial, participants generally met the following criteria: Body mass index (BMI) of 27 kg/m or above with at least one weight-related comorbidity (such as hypertension, dyslipidaemia, or obstructive sleep apnoea), or a BMI of 30 kg/m or above without comorbidities
is consulting with Novo Nordisk
By targeting these pathways, tirzepatide can help reduce hunger, improve portion control, and support steady, sustainable weight loss over time
